Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
1996-10-9
|
| pubmed:abstractText |
The aim of this study was to assess the medium and long-term results of the Carpentier-Edwards supra-annular (CESA 2650) bioprosthesis. From the end of 1984 to January 1993, 160 patients aged 71.6 +/- 8.6 years underwent aortic valve replacement alone or associated with coronary revascularisation. The postoperative mortality was 11 patients (6.8%): follow-up included 749 patient-years with an average period of 60 +/- 29 months, which was complete in 96% of operated patients. The late mortality was 30 patients (4% patients/year): the actuarial 5 year and 10 year survival was 78.6% and 59.1% respectively (hospital mortality included). The linear complications rates were: major thromboembolism: 1.3% patients/year; structural deterioration: 1.5% patients/year; reoperation: 0.75% patients/year; total morbid/fatal complications: 5% patients/year. Despite the limited follow-up, the authors' analysis confirmed the low rate of structural deterioration requiring reoperation, especially in patients over 70 years of age in whom there were no cases of reoperation at 9 years. They conclude that the medium-term results of the CESA 2650 bioprosthesis are comparable to those of first generation porcine bioprostheses: the absence of reoperation related to valve complications in the over 70s during the study period suggests that this is the replacement of choice in this category of patients.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0003-9683
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
88
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1841-6
|
| pubmed:dateRevised |
2009-2-13
|
| pubmed:meshHeading |
pubmed-meshheading:8729364-Actuarial Analysis,
pubmed-meshheading:8729364-Adult,
pubmed-meshheading:8729364-Aged,
pubmed-meshheading:8729364-Aged, 80 and over,
pubmed-meshheading:8729364-Anticoagulants,
pubmed-meshheading:8729364-Aortic Valve,
pubmed-meshheading:8729364-Bioprosthesis,
pubmed-meshheading:8729364-Endocarditis,
pubmed-meshheading:8729364-Female,
pubmed-meshheading:8729364-Follow-Up Studies,
pubmed-meshheading:8729364-Heart Valve Prosthesis,
pubmed-meshheading:8729364-Hemorrhage,
pubmed-meshheading:8729364-Humans,
pubmed-meshheading:8729364-Male,
pubmed-meshheading:8729364-Middle Aged,
pubmed-meshheading:8729364-Prosthesis Failure,
pubmed-meshheading:8729364-Retrospective Studies,
pubmed-meshheading:8729364-Survival Rate,
pubmed-meshheading:8729364-Thromboembolism
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
[Carpentier's supra-annular bioprosthesis in aortic position: a mid-term evaluation].
|
| pubmed:affiliation |
Service de chirurgie cardio-vasculaire B, CHU-Rangueil, Toulouse.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|